-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-app-f5-table-surveillance-report-2_0_0.xlsx
February 16, 2022 - Table F-5. Can. Cohort Studies
Table F-5. Cannabis cohort studies
PMID Author, Year Study Design Setting Pain Population Pain Condition Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race, Hispanic/Latino % Race, Asian % Race, Other % Pain Duration Measure
(Mean, Median) Pain Duration, Mon…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/Appendix-E-Table-E5_0.xlsx
November 04, 2021 - Table E-5. Can. Cohort Studies
Table E-5. Cannabis cohort studies
PMID Author, Year Study Design Setting Pain Population Pain Condition Age Measure (Mean, Median) Age, years Female % Race, White % Race, Black % Race, Hispanic/Latino % Race, Asian % Race, other % Pain Duration Measure
(Mean, Median) Pain Duration, Mon…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/masks-surveillance-2-report.pdf
October 01, 2020 - Masks for Prevention of COVID-19 in Community and Healthcare Settings: Surveillance Report
Surveillance Report: October 2020
Masks for Prevention of COVID-19 in
Community and Healthcare Settings:
Surveillance Report
Background
This surveillance report summarizes the search and update for the rapid review and li…
-
effectivehealthcare.ahrq.gov/products/allergy-seasonal/research-protocol
March 08, 2012 - Adverse effects, such as sedation, are therefore reduced. 27 The choice of which antihistamine to use … For children who are able and willing to use intranasal medication, nasal saline presents a treatment choice
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/peripheral-artery-disease-treatment_research-protocol.pdf
January 31, 2013 - The initial test of choice includes the simple
ABI measurement. … A number of trials have addressed the questions of aspirin dose and choice of antiplatelet
strategy, … trials, as well as other published literature, is needed to determine the aspirin dose
and optimal choice … Given these issues, the choice of revascularization strategy (endovascular versus surgical) is
often
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/undescended-testicle_executive.pdf
December 01, 2012 - 1
Comparative Effectiveness Review
Number 88
Evaluation and Treatment of Cryptorchidism
Executive Summary
Background
Cryptorchidism is a congenital condition
in which one or both testicles are not
appropriately positioned in the scrotum
at birth and cannot be moved into the
proper position manually. The term …
-
effectivehealthcare.ahrq.gov/sites/default/files/assessing-quality.ppt
January 01, 2010 - attributable to chance
Inferential Errors:
Result from problems in data analysis and interpretation, such as choice
-
effectivehealthcare.ahrq.gov/sites/default/files/hibbard-presentation.pdf
November 11, 2015 - approach.
19
What arethe implications for all of this for supporting theuseof information
and
choice
-
effectivehealthcare.ahrq.gov/sites/default/files/ebc-challenge-case-130621.pdf
June 01, 2013 - All teams were required to use the AHRQ Health Literacy
report, but had a choice to couple content from … The choice may be influenced
by the recommendations of strategic advisors, the host’s resources and
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-pci-bypass_addendum.pdf
February 01, 2010 - are similar after CABG and PCI in most patient
subgoups with multivessel coronary artery disease, so choice … effectiveness, since the extent of coronary disease is the strongest clinical factor affecting the
choice
-
effectivehealthcare.ahrq.gov/sites/default/files/ebc-challenge-webinar-transcript.pdf
June 01, 2014 - Teams had the choice of basing their
resources on evidence from
either the acute otitis media updates
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-future-value-of-information_research.pdf
June 01, 2011 - VOI Results
When we based our treatment choice decisions on duration of symptoms only, the baseline … Below that
threshold, gemcitabine alone is the cost-effective treatment of choice. … VOI Results
When we based our treatment choice decisions on effectiveness only, the population value
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/stem-cell-children_executive.pdf
February 01, 2012 - for a rapidly progressing lysosomal storage disorder such
as Wolman’s syndrome are clear; this is a choice
-
effectivehealthcare.ahrq.gov/products/major-depressive-disorder/research-protocol
June 19, 2014 - This review will focus on two key issues facing primary care physicians:
As an initial treatment choice … These options include adding a pharmacologic or nonpharmacologic treatment to the initial medication choice
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/antidepressants-update_executive.pdf
December 01, 2011 - Therefore, our findings indicate that the existing
evidence does not warrant the choice of one second … Nonetheless, some of these differences may be
clinically significant and influence the choice of a
medication
-
effectivehealthcare.ahrq.gov/products/depression-harms/research-protocol
February 07, 2018 - reported; thus, we will consider use of methods such as the Peto or Mantel-Haenzel odds ratios. 14 The choice
-
effectivehealthcare.ahrq.gov/sites/default/files/schwitzer_eccs2012.pdf
July 23, 2012 - Schwitzer_ECCS2012
Slide 1: Addressing
Tensions
When Popular Media and Evidence-‐Based Care
Collide
Gary
Schwitzer
Publisher,
HealthNewsReview.org
Slide 2: Infoxication
We are drowning people who are thirsty for just a sip of balanced infor…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/head-neck-cancer_executive.pdf
May 01, 2010 - Layout 1
Background
Head and neck cancers, specifically those
arising in the oral cavity, larynx,
hypopharynx, oropharynx, nasopharynx,
paranasal sinuses/nasal cavity, salivary
glands, and occult primaries, account for
approximately 3 to 5 percent of cancers in
the United States. According to the
National Comprehens…
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-240-acute-pain-revised-comments.pdf
December 29, 2020 - I had
no other choice than to go on Suboxone. I
was dependant on Opioids not addicted to
them. … more subtle reporting biases
found in this report is that opioids are
rarely a treatment of first choice … unrelieved pain and introduces the notion
that postoperative analgesia is not a
matter of a simple choice … Issues related to
choice of outcome tools and corporate
sponsorship further complicate
interpretation … Issues related to
choice of outcome tools and corporate
sponsorship further complicate
interpretation
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/thromboembolism-update-disposition.pdf
June 22, 2017 - the definition of sufficient evidence
excludes level I therapeutic evidence for
aspirin;
(2) the choice … Discussion we do talk about the
possibility of bias related to selective
outcome reporting and selective
choice … We would instead suggest that
industry bias (in choice of outcomes
and interventions) is made more … Conduct sensitivity analysis
using either model to see how the model
choice might impact the outcomes